ConductScience.org, home

Paper36744254

Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review.

Wu Q and 9 others. Front Pharmacol, 2023. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review. Papers, record 36744254. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36744254

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review.
PubMed
Journal
Front Pharmacol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
2.93
iCite
Revised in PubMed
2024-09-11
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu QQian
2Lv QQianyu
3Liu XXiao'an
4Ye XXuejiao
5Cao LLinlin
6Wang MManshi
7Li JJunjia
8Yang YYingtian
9Li LLanlan
10Wang SShihan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References198

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132624503Lipophagy: Molecular Mechanisms and Implications in Metabolic Disorders.Mol Cells2020https://conductscience.org/library/papers/32624503PubMed
224746805Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1.Cell Metab2014https://conductscience.org/library/papers/24746805PubMed
327744450Combination of Hydroxyl Acetylated Curcumin and Ultrasound Induces Macrophage Autophagy with Anti-Apoptotic and Anti-Lipid Aggregation Effects.Cell Physiol Biochem2016https://conductscience.org/library/papers/27744450PubMed
416293764Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients.Science2005https://conductscience.org/library/papers/16293764PubMed
526499876Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice.Mol Nutr Food Res2016https://conductscience.org/library/papers/26499876PubMed
626617799Quercetin increases macrophage cholesterol efflux to inhibit foam cell formation through activating PPARγ-ABCA1 pathway.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26617799PubMed
729773990Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy.Front Pharmacol2018https://conductscience.org/library/papers/29773990PubMed
831842027Tanshinone IIA protects mice against atherosclerotic injury by activating the TGF-β/PI3K/Akt/eNOS pathway.Coron Artery Dis2020https://conductscience.org/library/papers/31842027PubMed
934585416Loss of mTORC2-induced metabolic reprogramming in monocytes uncouples migration and maturation from production of proinflammatory mediators.J Leukoc Biol2022https://conductscience.org/library/papers/34585416PubMed
1015186745Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway.Curr Biol2004https://conductscience.org/library/papers/15186745PubMed
1123636326mTOR kinase structure, mechanism and regulation.Nature2013https://conductscience.org/library/papers/23636326PubMed
1226159807Tsc1 is a Critical Regulator of Macrophage Survival and Function.Cell Physiol Biochem2015https://conductscience.org/library/papers/26159807PubMed
1329317985Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke.Oxid Med Cell Longev2017https://conductscience.org/library/papers/29317985PubMed
1422500797mTOR signaling in growth control and disease.Cell2012https://conductscience.org/library/papers/22500797PubMed
1534905600The changing Nature of atherosclerosis: what we thought we knew, what we think we know, and what we have to learn.Eur Heart J2021https://conductscience.org/library/papers/34905600PubMed
1634810286Verbascoside inhibits the progression of atherosclerosis in high fat diet induced atherosclerosis rat model.J Physiol Pharmacol2021https://conductscience.org/library/papers/34810286PubMed
1721042876mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.Lipids2010https://conductscience.org/library/papers/21042876PubMed
1827566778A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.Genes Dev2016https://conductscience.org/library/papers/27566778PubMed
1927128486Nicotinate-Curcumin Impedes Foam Cell Formation from THP-1 Cells through Restoring Autophagy Flux.PLoS One2016https://conductscience.org/library/papers/27128486PubMed
2027098609Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.Nat Commun2016https://conductscience.org/library/papers/27098609PubMed

See all 198 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42657052Paeonol attenuates atherosclerosis by inhibiting mTOR via AMPK and SIRT1: Modulating lipid metabolism, autophagy, and pyroptosis.J Transl Int Med2026https://conductscience.org/library/papers/42657052PubMed
42193398Neuroimmune Regulation of Microvascular Inflammation: The Heart-Brain Axis, Mast Cells, and the Protective Role of Flavonoids-A Comprehensive Review.Biomedicines2026https://conductscience.org/library/papers/42193398PubMed
42178900Mettl8 Regulates Hippocampal Neural Stem Cell Proliferation and Neurogenesis via mTOR/4E-BP1 Signaling.CNS Neurosci Ther2026https://conductscience.org/library/papers/42178900PubMed
41917949Macrophage FTO deficiency accelerates atherosclerosis via PACS2-mediated activation of the PPARγ lipid signaling pathway.J Transl Med2026https://conductscience.org/library/papers/41917949PubMed
41829959Physiological and Recovery Responses to Dietary Polyphenols in the Context of Exercise: Relevance for Muscle Aging and Sarcopenia.Nutrients2026https://conductscience.org/library/papers/41829959PubMed
41676277Roles of autophagy in sepsis-induced myocardial dysfunction: a comprehensive review.Am J Transl Res2026https://conductscience.org/library/papers/41676277PubMed
41317009Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor From Selaginella inaequalifolia (Hook. & Grev.) Spring Ethanolic Extracts.Chem Biodivers2026https://conductscience.org/library/papers/41317009PubMed
41304802Nanostructured Delivery Systems for Curcumin: Improving Bioavailability and Plaque-Targeting Efficacy in Atherosclerosis.Pharmaceutics2025https://conductscience.org/library/papers/41304802PubMed
41007845Reimagining Oncologic Drugs in Atherosclerosis: Emerging Mechanisms and Therapeutic Potential.Biomedicines2025https://conductscience.org/library/papers/41007845PubMed
41001371Erastin-induced multi-pathway cell death in endometriosis: a mechanistic and translational narrative review.Front Med (Lausanne)2025https://conductscience.org/library/papers/41001371PubMed
40943647Lignin-Derived Oligomers as Promising mTOR Inhibitors: Insights from Dynamics Simulations.Int J Mol Sci2025https://conductscience.org/library/papers/40943647PubMed
40490937Antisenescence therapies for age-related bone loss: Target factors, medicines, biomedical materials.Clin Transl Med2025https://conductscience.org/library/papers/40490937PubMed
39062777Natural Compounds for Preventing Age-Related Diseases and Cancers.Int J Mol Sci2024https://conductscience.org/library/papers/39062777PubMed
38910885Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects.Front Pharmacol2024https://conductscience.org/library/papers/38910885PubMed
38565590Neuroprotective mechanisms of luteolin in glutamate-induced oxidative stress and autophagy-mediated neuronal cell death.Sci Rep2024https://conductscience.org/library/papers/38565590PubMed
38194294Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis.J Clin Invest2024https://conductscience.org/library/papers/38194294PubMed

Download CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36744254

GET https://conductscience.org/api/papers/v1/36744254/references?page=2